Literature DB >> 19271110

Gastric myoelectrical activity in patients with primary biliary cirrhosis.

Anna Kasicka-Jonderko1, Beata Krusiec-Swidergoł, Krzysztof Jonderko, Joanna Musialik, Maciej Gonciarz, Barbara Błońska-Fajfrowska, Zbigniew Gonciarz.   

Abstract

OBJECTIVE: To examine gastric myoelectrical activity in patients with primary biliary cirrhosis (PBC).
MATERIALS AND METHODS: The study comprised 11 female PBC patients (average age 53.4 years, range 43-70) and two aged-matched control groups: 11 (53.4 years, range 37-78) healthy women, and 10 female patients with chronic hepatitis C, CHC (53.9 years, range 35-66), who were examined prior to administration of an antiviral therapy. Every subject underwent an electrogastrographic recording comprising a 30-min interdigestive and a 120-min postprandial period.
RESULTS: Abnormal electrogastrograms, containing prolonged epochs of tachygastria in the postprandial phase were found in 2 out of 11 (18.2%) patients having both stage IV of the Scheuer's PBC classification, as well as in 1 patient out of 10 (10%) with CHC at stage F2 according to the METAVIR fibrosis score.
CONCLUSION: Electrogastrographic abnormalities do not seem to be pathognomonic for the PBC as a disease, but rather would be considered an unspecific sequel of a morbid liver affection.

Entities:  

Mesh:

Year:  2009        PMID: 19271110     DOI: 10.1007/s00535-009-0009-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  34 in total

1.  Impaired postprandial gastric myoelectrical activity in Chinese patients with nonulcer dyspepsia.

Authors:  C L Lu; C Y Chen; F Y Chang; L J Kang; S D Lee; H C Wu; T S Kuo
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

2.  Abnormal gastric slow waves in patients with functional dyspepsia assessed by multichannel electrogastrography.

Authors:  X Lin; J Z Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-06       Impact factor: 4.052

Review 3.  Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force.

Authors:  H P Parkman; W L Hasler; J L Barnett; E Y Eaker
Journal:  Neurogastroenterol Motil       Date:  2003-04       Impact factor: 3.598

4.  Pain: the overlooked symptom in gastroparesis.

Authors:  W A Hoogerwerf; P J Pasricha; A N Kalloo; M M Schuster
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

5.  Abnormalities of the electrogastrogram in functional gastrointestinal disorders.

Authors:  A Leahy; K Besherdas; C Clayman; I Mason; O Epstein
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

6.  Assessment of gastric electrical activity and autonomic function among diabetic and nondiabetic patients with symptoms of gastroesophageal reflux.

Authors:  A L Jackson; H Rashed; S Cardoso; F Wong; R Werkman; J Thompson; T L Abell
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

7.  Effect of single-dose administration of recombinant interferon-alpha2b on gastric myoelectrical activity in patients with chronic hepatitis C.

Authors:  Krzysztof Jonderko; Beata Krusiec-Swidergoł; Włodzimierz Mazur; Anna Kasicka-Jonderko; Maciej Gonciarz; Barbara Błońska-Fajfrowska; Zbigniew Gonciarz
Journal:  J Gastroenterol       Date:  2004-11       Impact factor: 7.527

8.  Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease.

Authors:  A M Madrid; F Cumsille; C Defilippi
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

9.  Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection.

Authors:  Han-Chung Lien; Wei Ming Sun; Yen-Hsueh Chen; Hyerang Kim; William Hasler; Chung Owyang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-03       Impact factor: 4.052

10.  Esophageal dysfunction in primary biliary cirrhosis.

Authors:  A Parés; L Grande; J Bruix; C Pera; J Rodés
Journal:  J Hepatol       Date:  1988-12       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.